Pilocarpine Hydrochloride Ophthalmic Solution/ Drops
NDC Package 60219-2649-1
Package Information
Pilocarpine Hydrochloride Ophthalmic (pilocarpine hydrochloride) solution/ dropses is pilocarpine hydrochloride ophthalmic solution is indicated for the treatment of presbyopia in adults. This formulation utilizes a solution/ drops delivery system. Marketed by Amneal Pharmaceuticals Ny Llc, this product is identified by NDC 60219-2649 and is authorized under FDA application ANDA217733.
Identification & Billing
- RxCUI: 2584552 - pilocarpine HCl 1.25 % Ophthalmic Solution
- RxCUI: 2584552 - pilocarpine hydrochloride 12.5 MG/ML Ophthalmic Solution
- RxCUI: 2584552 - pilocarpine hydrochloride 1.25 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60219 - Amneal Pharmaceuticals Ny Llc
- 60219-2649 - Pilocarpine Hydrochloride Ophthalmic
- 60219-2649-1 - 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
- 60219-2649 - Pilocarpine Hydrochloride Ophthalmic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60219-2649-1 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 5 ml in 1 bottle, dropper of Pilocarpine Hydrochloride Ophthalmic, a human prescription drug labeled by Amneal Pharmaceuticals Ny Llc. This solution/ drops is formulated for ophthalmic use and contains pilocarpine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Ny Llc on September 01, 2025. The current certification is valid through December 31, 2026.
How is this Amneal Pharmaceuticals Ny Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60219264901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.